NASDAQ : DRMA
Dermata Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.775 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.12M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 6.97M | 4.84M | 4.31M | 3.97M | 4.02M | 4.40M |
| Research & Development | 1.63M | 2.93M | 8.20M | 4.07M | 5.65M | 3.46M |
| Operating Expenses | 8.60M | 7.77M | 12.51M | 8.04M | 9.67M | 7.86M |
| Operating Income | -8.60M | -7.77M | -12.51M | -8.04M | -9.67M | -7.86M |
| Interest Expense | -45.61K | |||||
| Interest & Investment Income | 232.37K | 215.04K | 225.78K | 247.22K | 63.57K | |
| EBT Excluding Unusual Items | -8.37M | -7.56M | -12.29M | -7.79M | -9.61M | -7.90M |
| Pretax Income | -8.37M | -7.56M | -12.29M | -7.79M | -9.61M | -7.90M |
| Net Income | -8.37M | -7.56M | -12.29M | -7.79M | -9.61M | -7.90M |
| Preferred Dividends & Other Adjustments | 2.56M | |||||
| Net Income to Common | -8.37M | -7.56M | -12.29M | -7.79M | -9.61M | -10.46M |
| Shares Outstanding (Basic) | 2.51M | 926.19K | 152.97K | 19.49K | ||
| Shares Outstanding (Diluted) | 2.51M | 926.19K | 152.97K | 19.49K | ||
| EPS (Basic) | -3.33 | -8.16 | -80.32 | -399.87 | ||
| EPS (Diluted) | -3.33 | -8.16 | -80.32 | -399.87 | ||
| EBITDA | -7.86M | |||||
| D&A For EBITDA | 322.00 | |||||
| EBIT | -8.60M | -7.77M | -12.51M | -8.04M | -9.67M | -7.86M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.41M | 7.52M | 3.16M | 7.44M | 6.24M | 10.80M |
| Cash & Short-Term Investments | 4.41M | 7.52M | 3.16M | 7.44M | 6.24M | 10.80M |
| Other Receivables | 12.60K | |||||
| Receivables | 12.60K | |||||
| Prepaid Expenses | 208.31K | 309.11K | 359.72K | 449.27K | 598.01K | 769.42K |
| Other Current Assets | 385.29K | 32.74K | 12.60K | 91.23K | 92.58K | 55.72K |
| Total Current Assets | 5.16M | 7.86M | 3.53M | 7.98M | 6.94M | 11.62M |
| Property, Plant & Equipment | 70.50K | |||||
| Total Assets | 5.32M | 7.86M | 3.53M | 7.98M | 6.94M | 11.62M |
| Accounts Payable | 1.12M | 460.81K | 808.01K | 866.03K | 496.70K | 515.25K |
| Accrued Expenses | 713.36K | 1.18M | 1.16M | 757.59K | 425.93K | 1.00M |
| Total Current Liabilities | 1.83M | 1.64M | 1.97M | 1.62M | 922.63K | 1.52M |
| Total Liabilities | 1.83M | 1.64M | 1.97M | 1.62M | 922.63K | 1.52M |
| Common Stock | 402.00 | 266.00 | 25.00 | 26.00 | 77.00 | 833.00 |
| Additional Paid-In Capital | 81.54M | 79.46M | 67.24M | 59.74M | 51.61M | 46.09M |
| Retained Earnings | -78.05M | -73.23M | -65.68M | -53.39M | -45.59M | -35.98M |
| Total Common Equity | 3.49M | 6.22M | 1.56M | 6.36M | 6.02M | 10.11M |
| Shareholders' Equity | 3.49M | 6.22M | 1.56M | 6.36M | 6.02M | 10.11M |
| Total Liabilities & Equity | 5.32M | 7.86M | 3.53M | 7.98M | 6.94M | 11.62M |
| Net Cash (Debt) | 4.41M | 7.52M | 3.16M | 7.44M | 6.24M | 10.80M |
| Net Cash Per Share | 1.76 | 8.12 | 20.67 | 381.58 | ||
| Filing Date Shares Outstanding | 4.02M | 4.02M | 543.07K | 44.41K | ||
| Total Common Shares Outstanding | 4.02M | 2.66M | 251.78K | 26.21K | ||
| Working Capital | 3.32M | 6.22M | 1.56M | 6.36M | 6.02M | 10.11M |
| Book Value Per Share | 0.87 | 2.34 | 6.20 | 242.50 | ||
| Tangible Book Value | 3.43M | 6.22M | 1.56M | 6.36M | 6.02M | 10.11M |
| Tangible Book Value Per Share | 0.85 | 2.34 | 6.20 | 242.50 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -8.37M | -7.56M | -12.29M | -7.79M | -9.61M | -7.90M |
| Other Amortization | 14.13K | |||||
| Stock-Based Compensation | 152.37K | 143.73K | 657.65K | 522.08K | 930.33K | 1.91M |
| Change in Accounts Payable | 700.32K | -388.06K | -108.51K | 369.33K | -18.54K | 410.97K |
| Change in Other Net Operating Assets | -368.56K | 45.32K | 575.38K | 494.35K | -135.03K | -121.42K |
| Operating Cash Flow | -8.03M | -7.76M | -11.16M | -6.41M | -8.83M | -5.69M |
| Short-Term Debt Issued | 1.56M | |||||
| Total Debt Issued | 1.56M | |||||
| Long-Term Debt Repaid | -556.48K | |||||
| Net Debt Issued (Repaid) | 1.01M | |||||
| Issuance of Common Stock | 6.17M | 12.17M | 6.89M | 7.61M | 4.28M | 15.39M |
| Repurchase of Common Stock | -367.00 | -367.00 | -828.00 | -40.00 | ||
| Other Financing Activities | -91.35K | -50.49K | ||||
| Financing Cash Flow | 6.08M | 12.12M | 6.89M | 7.61M | 4.28M | 15.96M |
| Net Cash Flow | -2.07M | 4.36M | -4.28M | 1.20M | -4.56M | 10.27M |
| Levered Free Cash Flow | -5.11M | -5.02M | -6.65M | -3.64M | -5.59M | -2.49M |
| Unlevered Free Cash Flow | -5.11M | -5.02M | -6.65M | -3.64M | -5.59M | -2.48M |
| Cash Interest Paid | 1.42K | |||||
| Cash Income Tax Paid | 950.00 | 950.00 | 950.00 | 950.00 | 950.00 | 1.40K |
| Change in Working Capital | 182.02K | -342.73K | 466.86K | 863.68K | -153.58K | 289.55K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.12M | 6.17M | 2.76M | 2.16M | 4.95M | 14.49M |
| Enterprise Value | -1.30M | 1.51M | -3.39M | -4.47M | -3.12M | 1.89M |
| Last Close Price | 0.78 | 2.32 | 13.50 | 91.50 | 981.60 | 4,176.00 |
| PB Ratio | 0.89 | 0.99 | 1.76 | 0.34 | 0.82 | 1.43 |
| P/TBV Ratio | 0.91 | 0.99 | 1.76 | 0.34 | 0.82 | 1.43 |
| Net Debt / Equity Ratio | -1.26 | -1.21 | -2.02 | -1.17 | -1.04 | -1.07 |
| Net Debt / EBITDA Ratio | 1.37 | |||||
| Quick Ratio | 2.41 | 4.58 | 1.60 | 4.58 | 6.78 | 7.12 |
| Current Ratio | 2.81 | 4.79 | 1.79 | 4.91 | 7.53 | 7.66 |
| Return on Equity (ROE) | -183.89% | -194.20% | -310.44% | -125.96% | -119.18% | -228.09% |
| Return on Assets (ROA) | -89.88% | -85.25% | -135.86% | -67.36% | -65.13% | -80.31% |
| Return on Capital Employed (ROCE) | -246.60% | -124.90% | -801.60% | -126.50% | -160.70% | -77.70% |
| Earnings Yield | -430.13% | -122.48% | -446.00% | -361.07% | -194.19% | -54.53% |
| Buyback Yield / Dilution | -391.13% | -505.46% | -684.76% |